Atlas Trials

A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM

Clinical trial NCT05370508 · TERMINATED

Trial details

NCT number
NCT05370508
Sponsor
SonALAsense, Inc.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent GBM
Start date
2023-02-06
Primary completion
2024-06-11
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.